Document:

EXHIBIT
4.2

FORM
OF WARRANT TO PURCHASE SHARES

 

WARRANT
TO PURCHASE SHARES

 

THIS
WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATE. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED
OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS IN ACCORDANCE WITH APPLICABLE REGISTRATION REQUIREMENTS
OR AN EXEMPTION THEREFROM. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE ISSUER THAT
SUCH OFFER, SALE, TRANSFER, PLEDGE OR HYPOTHECATION OTHERWISE COMPLIES WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS. THIS WARRANT
MUST BE SURRENDERED TO THE COMPANY OR ITS TRANSFER AGENT AS A CONDITION PRECEDENT TO THE SALE, TRANSFER, PLEDGE OR HYPOTHECATION OF ANY
INTEREST IN ANY OF THE SECURITIES REPRESENTED HEREBY.

 

	Purchase
    Price	 	Dated
    as of __________, 2021
	

    [Warrant
    Purchase Price]
	 	

    Void
    after the date specified in Section 8

 

OPTI-HARVEST,
INC.

 

WARRANT
TO PURCHASE SHARES

 

No.
[Warrant Number]

 

THIS
CERTIFIES THAT, for value received, [Investor], or its registered assigns (the “Holder”), is entitled, subject to
the provisions and upon the terms and conditions set forth herein, to purchase from Opti-Harvest, Inc., a Delaware corporation
(the “Company”), Shares (as defined below), in the amounts, at such times and at the price per share set forth in
Section 1. The term “Warrant” as used herein shall include this Warrant and any warrants delivered in substitution
or exchange therefor as provided herein. This Warrant is issued in connection with the transactions described in the Note and Warrant
Purchase Agreement, dated as of ________________, 2021, by and among the Company and the Investors described therein (the “Note
and Warrant Purchase Agreement”). This Warrant is one of the series of “Warrants” issued pursuant to the Note and
Warrant Purchase Agreement. Capitalized terms not otherwise defined herein shall have the respective meanings ascribed to such terms
in the Note and Warrant Purchase Agreement and/or the form of subordinated convertible promissory note attached as Exhibit B to the Note
and Warrant Purchase Agreement (the “Note”, and together with each other Note issued pursuant to the Note and Warrant
Purchase Agreement, the “Notes”). The Holder of this Warrant is subject to certain restrictions as set forth in the
Note and Warrant Purchase Agreement.

 

    	 

    	 

    

 

The
following is a statement of the rights of the Holder and the conditions to which this Warrant is subject, and to which the Holder, by
acceptance of this Warrant, agrees:

 

1.
Number and Price of Shares; Exercise Period.

 

(a)
Definition of Shares. “Shares” shall mean the shares of Common Stock of the Company.

 

(b)
Number of Shares. Subject to any previous exercise of the Warrant, the Holder shall have the right to purchase up to the number
of Shares that equals the quotient obtained by dividing: (i) the Warrant Coverage Amount, by (ii) the Conversion Price,
prior to (or in connection with) the expiration of this Warrant as provided in Section 8.

 

(c)
Exercise Price. The exercise price per Share shall be equal to 115% of the offering price per share of common stock of the Company
in its first underwritten public offering (the “IPO”) pursuant to an effective registration
statement under the Securities Act of 1933, as amended, covering the offer and sale by the Company of not less than $10,000,000 of its
equity securities, as a result of or following which the Company shall be a reporting issuer under the Securities and Exchange Act of
1934, as amended, and its common stock shall be listed on the Nasdaq Stock Market, subject to adjustment pursuant hereto (the
“Exercise Price”).

 

(d)
Exercise Period. This Warrant shall be exercisable, in whole or in part: (i) after the earlier to occur of: (A) the consummation
of the IPO; or (B) six months after the date of this Warrant; and (ii) prior to (or in connection with) the expiration of this Warrant
as set forth in Section 8.

 

(e)
Warrant Coverage Amount. The “Warrant Coverage Amount” shall mean the amount obtained by multiplying:
(A) one hundred percent (100%); by (B) aggregate principal amount of the Holder’s Note(s) delivered pursuant to the Note
and Warrant Purchase Agreement.

 

2.
Exercise of the Warrant.

 

(a)
Exercise. The purchase rights represented by this Warrant may be exercised at the election of the Holder, in whole or in part,
in accordance with Section 1, by:

 

(i)
the tender to the Company at its principal office (or such other office or agency as the Company may designate) of a notice of exercise,
in the form of Exhibit A hereto (the “Notice of Exercise”), duly completed and executed by or on behalf of
the Holder, together with the surrender of this Warrant; and

 

(ii)
the payment to the Company of an amount equal to: (A) the Exercise Price; multiplied by (B) the number of Shares being purchased,
by wire transfer or certified, cashier’s or other check acceptable to the Company and payable to the order of the Company.

 

(b)
Net Issue Exercise. If the Shares underlying this Warrant are not registered as part of the Company’s registration statement
the subject of its IPO and filed with the Securities and Exchange Commission within six months of the date of issuance of this Warrant,
then in lieu of exercising this Warrant pursuant to Section 2(a)(ii), if the fair market value of one Share is greater than the
Exercise Price (at the date of calculation as set forth below), the Holder may elect to receive a number of Shares equal to the value
of this Warrant (or of any portion of this Warrant being cancelled) by surrender of this Warrant at the principal office of the Company
(or such other office or agency as the Company may designate), together with a properly completed and executed Notice of Exercise reflecting
such election, in which event the Company shall issue to the Holder that number of Shares computed using the following formula:

 

	 	 	 	 	 
		X	=	     Y
    (A – B)	 
	 	 		A	 

 

    	 

    	 

    

 

Where:

 

	 	X	=	The
    number of Shares to be issued to the Holder.
	 	 	 	 
	 	Y	=	The
    number of Shares purchasable under this Warrant or, if only a portion of the Warrant is being exercised, the portion of the Warrant
    being cancelled (at the date of such calculation).
	 	 	 	 
	 	A	=	The
    fair market value of one Share (at the date of such calculation).
	 	 	 	 
	 	B	=	The
    Exercise Price (as adjusted to the date of such calculation).

 

For
purposes of the calculation above, the fair market value of one Share shall be determined by the Board of Directors of the Company, acting
in good faith; provided, however, that:

 

(i)
where a public market exists for the Company’s common stock at the time of such exercise, the fair market value per Share shall
be the product of: (A) the average of the closing bid prices of the Common Stock or the closing price quoted on the national securities
exchange on which the Common Stock is listed as published in the Wall Street Journal, as applicable, for the ten (10) trading
day period ending five (5) trading days prior to the date of determination of the fair market value; and (B) the number of shares of
Common Stock into which each Share is convertible at the time of such exercise, as applicable; and

 

(ii)
if the Warrant is exercised in connection with the Company’s initial public offering of Common Stock, the fair market value per
Share shall be the product of: (A) the per share offering price to the public of the Company’s initial public offering; and (B)
the number of shares of Common Stock into which each Share is convertible at the time of such exercise, as applicable.

 

(c)
Stock Certificates. The rights under this Warrant shall be deemed to have been exercised and the Shares issuable upon such exercise
shall be deemed to have been issued immediately prior to the close of business on the date this Warrant is exercised in accordance with
its terms, and the person entitled to receive the Shares issuable upon such exercise shall be treated for all purposes as the holder
of record of such Shares as of the close of business on such date. As promptly as reasonably practicable on or after such date, the Company
shall issue and deliver to the person or persons entitled to receive the same a certificate or certificates for that number of Shares
issuable upon such exercise. In the event that the rights under this Warrant are exercised in part and have not expired, the Company
shall execute and deliver a new Warrant reflecting the number of Shares that remain subject to this Warrant.

 

    	 

    	 

    

 

(d)
No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of the rights under this Warrant. In lieu of such fractional share to which the Holder would otherwise be entitled, the Company shall
make a cash payment equal to the Exercise Price multiplied by such fraction of a share.

 

(e)
Conditional Exercise. The Holder may exercise this Warrant conditioned upon (and effective immediately prior to) consummation
of any transaction that would cause the expiration of this Warrant pursuant to Section 8 by so indicating in the Notice of Exercise.

 

(f)
Automatic Exercise Upon Change of Control. To the extent this Warrant is not previously exercised and if the Company will consummate
a Change of Control, this Warrant shall be deemed automatically exercised in accordance with Section 2(b) above (even if not surrendered)
immediately prior to the consummation of such Change of Control; provided, however, that the Holder may, at the Holder’s
option, elect to exercise this Warrant in accordance with Section 2(a) above prior to the Company’s consummation of such
Change of Control. To the extent this Warrant or any portion thereof is deemed automatically exercised pursuant to this Section 2(f),
the Company (or its successor entity) agrees to notify the Holder within a reasonable period of time of the number of Shares, if any
(or the consideration payable for such number of Shares in connection with such Change of Control, if any), that the Holder is entitled
to receive by reason of such automatic exercise. If applicable, the Company shall not be required to deliver any stock certificate(s)
evidencing any Shares issuable upon such automatic exercise unless and until the Company has received the original of this Warrant. The
Company shall provide the Holder with prior notice of the Company’s contemplated consummation of any such Change of Control in
accordance with Section 7 below.

 

(g)
Reservation of Stock. The Company agrees during the term the rights under this Warrant are exercisable to take all reasonable
action to reserve and keep available from its authorized and unissued shares of Preferred Stock for the purpose of effecting the exercise
of this Warrant such number of shares (and shares of Common Stock for issuance on conversion of such shares) as shall from time to time
be sufficient to effect the exercise of the rights under this Warrant; and if at any time the number of authorized but unissued shares
of Preferred Stock (and shares of Common stock for issuance upon conversion of such shares) shall not be sufficient for purposes of the
exercise of this Warrant in accordance with its terms and the conversion of the Shares, without limitation of such other remedies as
may be available to the Holder, the Company will use reasonable efforts to take such corporate action as may, in the opinion of counsel,
be necessary to increase its authorized and unissued shares of its Preferred Stock (and shares of Common Stock for issuance on conversion
of such shares) to a number of shares as shall be sufficient for such purposes.

 

3.
Replacement of the Warrant. Subject to the receipt of evidence reasonably satisfactory to the Company of the loss, theft,
destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, upon delivery of an indemnity agreement reasonably
satisfactory in form and substance to the Company or, in the case of mutilation, upon surrender and cancellation of this Warrant, the
Company at the expense of the Holder shall execute and deliver, in lieu of this Warrant, a new warrant of like tenor and amount.

 

    	 

    	 

    

 

4.
Transfer of the Warrant.

 

(a)
Warrant Register. The Company shall maintain a register (the “Warrant Register”) containing the name and address
of the Holder or Holders. Until this Warrant is transferred on the Warrant Register in accordance herewith, the Company may treat the
Holder as shown on the Warrant Register as the absolute owner of this Warrant for all purposes, notwithstanding any notice to the contrary.
Any Holder of this Warrant (or of any portion of this Warrant) may change its address as shown on the Warrant Register by written notice
to the Company requesting such a change of address.

 

(b)
Warrant Agent. The Company may appoint an agent for the purpose of maintaining the Warrant Register referred to in Section
4(a), issuing the Shares or other securities then issuable upon the exercise of the rights under this Warrant, exchanging this Warrant,
replacing this Warrant or conducting related activities.

 

(c)
Transferability of the Warrant. Subject to the provisions of this Warrant with respect to compliance with the Securities Act and
limitations on assignments and transfers, including, without limitation, compliance with the restrictions on transfer set forth in Section
5, title to this Warrant may be transferred by endorsement (by the transferor and the transferee executing the assignment form, attached
hereto as Exhibit B (the “Assignment Form”)), and delivery in the same manner as a negotiable instrument transferable
by endorsement and delivery.

 

(d)
Exchange of the Warrant upon a Transfer. On surrender of this Warrant (and a properly endorsed Assignment Form) for exchange,
subject to the provisions of this Warrant with respect to compliance with the Securities Act and limitations on assignments and transfers,
the Company shall issue to or on the order of the Holder a new warrant or warrants of like tenor, in the name of the Holder or as the
Holder (on payment by the Holder of any applicable transfer taxes) may direct, for the number of Shares issuable upon exercise hereof,
and the Company shall register any such transfer upon the Warrant Register. This Warrant (and the securities issuable upon exercise of
the rights under this Warrant) must be surrendered to the Company or its warrant or transfer agent, as applicable, as a condition precedent
to the sale, pledge, hypothecation or other transfer of any interest in any of the securities represented hereby.

 

(e)
Taxes. In no event shall the Company be required to pay any tax which may be payable in respect of any transfer involved in the
issue and delivery of any certificate in a name other than that of the Holder, and the Company shall not be required to issue or deliver
any such certificate unless and until the person or persons requesting the issue thereof shall have paid to the Company the amount of
such tax or shall have established to the satisfaction of the Company that such tax has been paid or is not payable.

 

    	 

    	 

    

 

5.
Restrictions on Transfer of the Warrant and Shares; Compliance with Securities Laws. By acceptance of this Warrant, the
Holder agrees to comply with the following:

 

(a)
Restrictions on Transfers. Subject to Section 5(b) below, this Warrant may not be transferred or assigned, in whole or
in part, without the Company’s prior written consent (which shall not be unreasonably withheld), and any attempt by the Holder
to transfer or assign any rights, duties or obligations that arise under this Warrant without such permission shall be void. Any transfer
of this Warrant or the Shares or the shares of Common Stock issuable upon conversion of the Shares (the “Securities”)
must be in compliance with all applicable federal and state securities laws. The Holder agrees not to make any sale, assignment, transfer,
pledge or other disposition of all or any portion of the Securities, or any beneficial interest therein, unless and until the transferee
thereof has agreed in writing for the benefit of the Company to take and hold such Securities subject to, and to be bound by, the terms
and conditions set forth in this Warrant to the same extent as if the transferee were the original Holder hereunder, and

 

(i)
there is then in effect a registration statement under the Securities Act covering such proposed disposition and such disposition is
made in accordance with such registration statement, or

 

(ii)(A)
such Holder shall have given prior written notice to the Company of such Holder’s intention to make such disposition and shall
have furnished the Company with a detailed description of the manner and circumstances of the proposed disposition, (B) the transferee
shall have confirmed to the satisfaction of the Company in writing, in substantially the form of Exhibit A-1 hereto, that the
Securities are being acquired (1) solely for the transferee’s own account and not as a nominee for any other party, (2) for investment
and (3) not with a view toward distribution or resale, and shall have confirmed such other matters related thereto as may be reasonably
requested by the Company, and (C) if requested by the Company, such Holder shall have furnished the Company, at the Holder’s expense,
with evidence satisfactory to the Company that such disposition will not require registration of such Securities under the Securities
Act, whereupon such Holder shall be entitled to transfer such Securities in accordance with the terms of the notice delivered by such
Holder to the Company. The Company agrees that it will not require an opinion of counsel for a transfer pursuant to Rule 144 of the Securities
Act except in unusual circumstances.

 

(b)
Permitted Transfers. The following transfers shall not be subject to Section 5(a): (i) a transfer not involving a change
in beneficial ownership; or (ii) transactions involving the distribution without consideration of Securities by any Holder to: (A) a
parent, subsidiary or other affiliate of a Holder that is a corporation, (B) any of the Holder’s partners, members or other equity
owners, or retired partners or members, or to the estate of any of its partners, members or other equity owners or retired partners or
members, or (C) a venture capital fund that is controlled by or under common control with one or more general partners or managing members
of, or shares the same management company with, the Holder; provided, however, in each case, that the Holder shall give
written notice to the Company of the Holder’s intention to effect such disposition and shall have furnished the Company with a
detailed description of the manner and circumstances of the proposed disposition.

 

(c)
Investment Representation Statement. Unless the rights under this Warrant are exercised pursuant to an effective registration
statement under the Securities Act that includes the Shares with respect to which the Warrant was exercised, it shall be a condition
to any exercise of the rights under this Warrant that the Holder shall have confirmed to the satisfaction of the Company in writing,
in substantially the form of Exhibit A-1 hereto, that the Shares so purchased are being acquired solely for the Holder’s
own account and not as a nominee for any other party, for investment and not with a view toward distribution or resale and that the Holder
shall have confirmed such other matters related thereto as may be reasonably requested by the Company.

 

    	 

    	 

    

 

(d)
Securities Law Legend. The Securities shall (unless otherwise permitted by the provisions of this Warrant) be stamped or imprinted
with a legend substantially similar to the following (in addition to any legend required by state securities laws):

 

THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR
UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED
EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS IN ACCORDANCE WITH APPLICABLE REGISTRATION REQUIREMENTS OR AN
EXEMPTION THEREFROM. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE ISSUER THAT SUCH
OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION OTHERWISE COMPLIES WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS. THIS CERTIFICATE
MUST BE SURRENDERED TO THE COMPANY OR ITS TRANSFER AGENT AS A CONDITION PRECEDENT TO THE SALE, TRANSFER, PLEDGE OR HYPOTHECATION OF ANY
INTEREST IN ANY OF THE SECURITIES REPRESENTED HEREBY.

 

(e)
Market Stand-off Legend. The Shares and Common Stock issued upon exercise hereof or conversion thereof shall also be stamped or
imprinted with a legend in substantially the following form:

 

THE
SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE, INCLUDING A LOCK-UP PERIOD IN THE EVENT
OF A PUBLIC OFFERING, AS SET FORTH IN THE WARRANT PURSUANT TO WHICH THESE SHARES WERE ISSUED, A COPY OF WHICH MAY BE OBTAINED AT THE
PRINCIPAL OFFICE OF THE COMPANY.

 

(f)
Instructions Regarding Transfer Restrictions. The Holder consents to the Company making a notation on its records and giving instructions
to any transfer agent in order to implement the restrictions on transfer established in this Section 5.

 

(g)
Removal of Legend. The legend referring to federal and state securities laws identified in Section 5(c) stamped on a certificate
evidencing the Shares (and the Common Stock issuable upon conversion thereof) and the stock transfer instructions and record notations
with respect to such securities shall be removed and the Company shall issue a certificate without such legend to the holder of such
securities if: (i) such securities are registered under the Securities Act; or (ii) such holder provides the Company with an opinion
of counsel reasonably acceptable to the Company to the effect that a sale or transfer of such securities may be made without registration
or qualification.

 

    	 

    	 

    

 

6.
Adjustments. Subject to the expiration of this Warrant pursuant to Section 8, the number and kind of Shares purchasable
hereunder and the Exercise Price therefor are subject to adjustment from time to time, as follows:

 

(a)
Merger or Reorganization. If at any time there shall be any reorganization, recapitalization, merger or consolidation (a “Reorganization”)
involving the Company (other than as otherwise provided for herein or as would cause a deemed net exercise pursuant to Section 2(f))
in which shares of the Company’s stock are converted into or exchanged for securities, cash or other property, then, as a part
of such Reorganization, lawful provision shall be made so that the Holder shall thereafter be entitled to receive upon exercise of this
Warrant, the kind and amount of securities, cash or other property of the successor corporation resulting from such Reorganization, equivalent
in value to that which a holder of the Shares deliverable upon exercise of this Warrant would have been entitled in such Reorganization
if the right to purchase the Shares hereunder had been exercised immediately prior to such Reorganization. In any such case, appropriate
adjustment (as determined in good faith by the Board of Directors of the successor corporation) shall be made in the application of the
provisions of this Warrant with respect to the rights and interests of the Holder after such Reorganization to the end that the provisions
of this Warrant shall be applicable after the event, as near as reasonably may be, in relation to any shares or other securities deliverable
after that event upon the exercise of this Warrant.

 

(b)
Reclassification of Shares. If the Securities issuable upon exercise of this Warrant are changed into the same or a different
number of securities of any other class or classes by reclassification, capital reorganization, conversion of all outstanding shares
of the relevant class or series (other than as would cause the expiration of this Warrant pursuant to Section 8) or otherwise
(other than as otherwise provided for herein) (a “Reclassification”), then, in any such event, in lieu of the number
of Shares which the Holder would otherwise have been entitled to receive, the Holder shall have the right thereafter to exercise this
Warrant for a number of shares of such other class or classes of stock that a holder of the number of Securities deliverable upon exercise
of this Warrant immediately before that change would have been entitled to receive in such Reclassification, all subject to further adjustment
as provided herein with respect to such other shares.

 

(c)
Subdivisions and Combinations. In the event that the outstanding shares of the Securities issuable upon exercise of this Warrant
are subdivided (by stock split, by payment of a stock dividend or otherwise) into a greater number of shares of such Securities, the
number of Shares issuable upon exercise of the rights under this Warrant immediately prior to such subdivision shall, concurrently with
the effectiveness of such subdivision, be proportionately increased, and the Exercise Price shall be proportionately decreased, and in
the event that the outstanding shares of the Securities issuable upon exercise of this Warrant are combined (by reclassification or otherwise)
into a lesser number of shares of such Securities, the number of Shares issuable upon exercise of the rights under this Warrant immediately
prior to such combination shall, concurrently with the effectiveness of such combination, be proportionately decreased, and the Exercise
Price shall be proportionately increased.

 

(d)
Notice of Adjustments. Upon any adjustment in accordance with this Section 6, the Company shall give notice thereof to
the Holder, which notice shall state the event giving rise to the adjustment, the Exercise Price as adjusted and the number of securities
or other property purchasable upon the exercise of the rights under this Warrant, setting forth in reasonable detail the method of calculation
of each. The Company shall, upon the written request of any Holder, furnish or cause to be furnished to such Holder a certificate setting
forth: (i) such adjustments; (ii) the Exercise Price at the time in effect; and (iii) the number of securities and the amount, if any,
of other property that at the time would be received upon exercise of this Warrant.

 

    	 

    	 

    

 

7.
Notification of Certain Events. Prior to the expiration of this Warrant pursuant to Section 8, in the event that
the Company shall authorize:

 

(a)
the issuance of any dividend or other distribution on the capital stock of the Company (other than: (i) dividends or distributions otherwise
provided for in Section 6; (ii) repurchases of Common Stock issued to or held by employees, officers, directors or consultants
of the Company or its subsidiaries upon termination of their employment or services pursuant to agreements providing for the right of
said repurchase; (iii) repurchases of Common Stock issued to or held by employees, officers, directors or consultants of the Company
or its subsidiaries pursuant to rights of first refusal or first offer contained in agreements providing for such rights; or (iv) repurchases
of capital stock of the Company in connection with the settlement of disputes with any stockholder), whether in cash, property, stock
or other securities;

 

(b)
the voluntary liquidation, dissolution or winding up of the Company;

 

(c)
a Change of Control; or

 

(d)
any transaction resulting in the expiration of this Warrant pursuant to Section 8(b).

 

the
Company shall send to the Holder of this Warrant at least ten (10) calendar days prior written notice of the date on which a record shall
be taken for any such dividend or distribution specified in clause (a) or the expected effective date of any such other event specified
in clause (b), (c) or (d), as applicable. The notice provisions set forth in this Section 7 may be shortened or waived prospectively
or retrospectively by the consent of the holders of greater than fifty percent (50%) of the aggregate Warrant Coverage Amount of all
Warrants issued pursuant to the Note and Warrant Purchase Agreement (a “Majority in Interest of Warrant Holders”).

 

8.
Expiration of the Warrant. This Warrant shall expire and shall no longer be exercisable as of 5:00 p.m., Pacific time,
on ______________, 2024.

 

9.
No Rights as a Stockholder. Nothing contained herein shall entitle the Holder to any rights as a stockholder of the Company
or to be deemed the holder of any securities that may at any time be issuable on the exercise of the rights hereunder for any purpose
nor shall anything contained herein be construed to confer upon the Holder, as such, any right to vote for the election of directors
or upon any matter submitted to stockholders at any meeting thereof, or to give or withhold consent to any corporate action (whether
upon any recapitalization, issuance of stock, reclassification of stock, change of par value or change of stock to no par value, consolidation,
merger, conveyance or otherwise) or to receive notice of meetings, or to receive dividends or subscription rights or any other rights
of a stockholder of the Company until the rights under the Warrant shall have been exercised and the Shares purchasable upon exercise
of the rights hereunder shall have become deliverable as provided herein.

 

    	 

    	 

    

 

10.
Market Stand-off. Each Holder agrees that all Shares shall be subject to the market standoff provisions of Section 2.10
of that certain Investors’ Rights Agreement dated the date hereof, by and between the Company and the first purchaser of this Warrant.

 

11.
Miscellaneous.

 

(a)
Amendments. Except as expressly provided herein, neither this Warrant nor any term hereof may be amended, waived, discharged or
terminated other than by a written instrument referencing this Warrant and signed by the Company and a Majority in Interest of the Warrant
Holders; provided, however, that in no event may any such amendment, waiver, discharge or termination materially adversely
affect any holder of a Warrant in a different or disproportionate manner than the other holders of Warrants issued under the Note and
Warrant Purchase Agreement unless agreed to in writing by such materially adversely affected holder. Any amendment, waiver, discharge
or termination effected in accordance with this Section 11(a) shall be binding upon each holder of the Warrants, each future holder
of such Warrants and the Company; provided, however, that no special consideration or inducement may be given to any such holder
in connection with such consent that is not given ratably to all such holders, and that such amendment must apply to all such holders
equally and ratably in accordance with the number of shares of capital stock issuable upon exercise of the Warrants. The Company shall
promptly give notice to all holders of Warrants of any amendment effected in accordance with this Section 11(a).

 

(b)
Waivers. No waiver of any single breach or default shall be deemed a waiver of any other breach or default theretofore or thereafter
occurring.

 

(c)
Notices. All notices and other communications required or permitted hereunder shall be in writing and shall be mailed by registered
or certified mail, postage prepaid, sent by facsimile or electronic mail (if to the Holder) or otherwise delivered by hand, messenger
or courier service addressed:

 

(i)
if to the Holder, to the Holder at the Holder’s address, facsimile number or electronic mail address as shown in the Company’s
records, as may be updated in accordance with the provisions hereof, or until any such Holder so furnishes an address, facsimile number
or electronic mail address to the Company, then to and at the address, facsimile number or electronic mail address of the last holder
of this Warrant for which the Company has contact information in its records; or

 

(ii)
if to the Company, to the attention of the Chief Executive Officer or the Chief Financial Officer of the Company at the Company’s
address as shown on the signature page hereto, or at such other address as the Company shall have furnished to the Holder, with a copy
(which shall not constitute notice) to Thomas E. Puzzo, Law Offices of Thomas E. Puzzo, PLLC, 3823 44th Ave. NE, Seattle, Washington
98105.

 

Each
such notice or other communication shall for all purposes of this Warrant be treated as effective or having been given: (A) if delivered
by hand, messenger or courier service, when delivered; (B) if sent by mail, at the earlier of its receipt or 72 hours after the same
has been deposited in a regularly maintained receptacle for the deposit of the United States mail, addressed and mailed as aforesaid;
or (C) if sent by facsimile, upon confirmation of facsimile transfer or, if sent by electronic mail, upon confirmation of delivery when
directed to the relevant electronic mail address. In the event of any conflict between the Company’s books and records and this
Warrant or any notice delivered hereunder, the Company’s books and records will control absent fraud or error.

 

    	 

    	 

    

 

(d)
Governing Law. This Warrant and all actions arising out of or in connection with this Warrant shall be governed by and construed
in accordance with the laws of the State of Delaware, without regard to the conflicts of law provisions of the State of Delaware or of
any other state.

 

(e)
Titles and Subtitles. The titles and subtitles used in this Warrant are used for convenience only and are not to be considered
in construing or interpreting this Warrant. All references in this Warrant to sections, paragraphs and exhibits shall, unless otherwise
provided, refer to sections and paragraphs hereof and exhibits attached hereto.

 

(f)
Severability. If any provision of this Warrant becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable
or void, portions of such provision, or such provision in its entirety, to the extent necessary, shall be severed from this Warrant,
and such illegal, unenforceable or void provision shall be replaced with a valid and enforceable provision that will achieve, to the
extent possible, the same economic, business and other purposes of the illegal, unenforceable or void provision. The balance of this
Warrant shall be enforceable in accordance with its terms.

 

(g)
Waiver of Jury Trial. EACH OF THE HOLDER AND THE COMPANY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY AND ALL RIGHT TO
TRIAL BY JURY IN ANY LEGAL PROCEEDING (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATED TO THIS WARRANT. This
Section 11(g) shall not restrict the Holder or the Company from exercising remedies under the Uniform Commercial Code or from
exercising pre-judgment remedies under applicable law.

 

(h)
California Corporate Securities Law. THE SALE OF THE SECURITIES THAT ARE THE SUBJECT OF THIS WARRANT HAS NOT BEEN QUALIFIED WITH
THE COMMISSIONER OF CORPORATIONS OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF SUCH SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART
OF THE CONSIDERATION THEREFOR PRIOR TO SUCH QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM QUALIFICATION BY
SECTION 25100, 25102, OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS WARRANT ARE EXPRESSLY CONDITIONED
UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.

 

(i)
Rights and Obligations Survive Exercise of the Warrant. Except as otherwise provided herein, the rights and obligations of the
Company and the Holder under this Warrant shall survive exercise of this Warrant.

 

(j)
Entire Agreement. Except as expressly set forth herein, this Warrant (including the exhibits attached hereto), the Notes, the
Note and Warrant Purchase Agreement and the other Transaction Documents constitute the entire agreement and understanding of the Company
and the Holder with respect to the subject matters hereof and thereof and supersede all prior agreements and understandings relating
to the subject matters hereof and thereof.

 

(Signature
Page Follows)

 

    	 

    	 

    

 

The
Company signed this Warrant as of the date first written above.

 

	 	COMPANY:
	 	 
	 	OPTI-HARVEST,
    INC.
	 	 	 
	 	By:	 
	 	Name:
    	Jonathan
    Destler
	 	Title:	Chief
    Executive Officer
	 	 	 
	 	Address:
	 	1801
    Century Park East, Suite 520
	 	Los
    Angeles, California 90067

 

(Signature
Page to Opti-Harvest, Inc. Warrant)

 

    	 

    	 

    

 

EXHIBIT
A

 

NOTICE
OF EXERCISE

 

	TO:	 	OPTI-HARVEST,
    INC. (the “Company”) 
	 	 	 
	Attention:	 	Chief
    Executive Officer

 

	(1)
    Exercise.	The
    undersigned elects to purchase the following pursuant to the terms of the attached Warrant:

 

	 	Number
    of shares:	 
	 	 	 	 
	 	Type
    of security:	 

 

	(2)
    Method of Exercise.	The
    undersigned elects to exercise the attached Warrant pursuant to:

 

	 	☐	A
    cash payment, and tenders herewith payment of the purchase price for such shares in full, together with all applicable transfer taxes,
    if any.
	 		
	 	☐	The
    net issue exercise provisions of Section 2(b) of the attached Warrant.

 

	(3)
    Conditional Exercise.	Is
    this a conditional exercise pursuant to Section 2(e):

 

	 	☐	Yes	☐	No	 

 

	 	If
    “Yes,” indicate the applicable condition:
	 	 
	 	]

 

	(4)
    Stock Certificate.	Please
    issue a certificate or certificates representing the shares in the name of:

 

	 	☐	The
    undersigned	 
	 	 	 	 
	 	☐	Other—Name:	
	 	 	 	 
	 	 	Address:	
	 	 	 	 
	 	 	 	 

 

    	 

    	 

    

 

	(5)
    Unexercised Portion of the Warrant.	Please
                                            issue a new warrant for the unexercised portion of the attached
                                            Warrant in the name of:

 

	 	☐	The
    undersigned	 
	 	 	 	 
	 	☐	Other—Name:	
	 	 	 	 
	 	 	Address:	 
	 	 	 	 
	 	 	 	
	 	☐	Not
    applicable	 

 

	(6)	 	Investment
    Intent. The undersigned represents and warrants that the aforesaid shares are being acquired for investment for its own account,
    not as a nominee or agent, and not with a view to, or for resale in connection with, the distribution thereof, and that the undersigned
    has no present intention of selling, granting any participation in, or otherwise distributing the shares, nor does it have any contract,
    undertaking, agreement or arrangement for the same.

 

	(7)	 	Investment
    Representation Statement and Market Stand-Off Agreement. The undersigned has executed, and delivers herewith, an Investment
    Representation Statement and Market Stand-Off Agreement in a form substantially similar to the form attached to the Warrant as Exhibit
    A-1.

 

	(8)	 	Consent
    to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § 232(e),
    the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation
    Law or the Company’s Certificate of Incorporation or Bylaws by: (i) facsimile telecommunication to the facsimile number provided
    below (or to any other facsimile number for the undersigned in the Company’s records); (ii) electronic mail to the electronic
    mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); (iii) posting
    on an electronic network together with separate notice to the undersigned of such specific posting; or (iv) any other form of electronic
    transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the
    undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation
    Law § 232.

 

		
	 	
	 	(Print
    name of the warrant holder)
	 	
		(Signature)
	 

    
	
		(Name
    and title of signatory, if applicable)
	 

    
	
		(Date)
	 

    
	
		(Fax
    number)
	 	
	 

    
	(Email
    address)  

 

(Signature
Page to the Notice of Exercise)EXHIBIT
4.3

 

FORM
OF SENIOR CONVERTIBLE PROMISSORY NOTE

 

NEITHER
THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON
CONVERSION OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

OPTI-HARVEST,
INC.

 

SENIOR
CONVERTIBLE PROMISSORY NOTE

 

	$___________	_____________,
    2021

 

Opti-Harvest,
Inc., a Delaware corporation (“Obligor”), for value received, hereby promises to pay to the order of _______________,
a _____________ corporation (“Payee”), the aggregate principal amount outstanding of _____________ United States Dollars
($______________; the “Principal”) under this Senior Convertible Promissory Note (hereinafter sometimes referred to
as this “Note”) upon maturity as set forth below together with interest as set forth herein. Interest on this Note
shall be computed on the basis of a year of 365 days for the actual number of days elapsed.

 

This
Note carries an original issue discount of $_____________, amounting to 15% of the Principal.

 

1.
Note and Warrant Purchase Agreement. This Note is being issued in conjunction with that certain Note and Warrant Purchase
Agreement of even date herewith (the “Purchase Agreement”) where the capitalized terms used herein shall have the
meanings prescribed for in the Purchase Agreement. The debts, liabilities and obligations of Obligor to Payee under this Note, including
all unpaid principal and all interest accrued hereon, whether due or to become due, absolute or contingent, liquidated or unliquidated,
determined or undetermined shall be referred to as the “Obligations”. All payments shall be applied first to accrued
interest, and thereafter to principal.

 

    	 

     

    

 

2.
Interest Rate. The outstanding principal amount shall bear interest from the date of this Note at a rate of twelve percent
(12%) per annum (the “Interest Rate”). Interest shall be computed on the basis of the actual number of days elapsed and a
year of three hundred sixty (360) days. Notwithstanding any provision in this Note to the contrary,
any interest payable hereunder shall automatically accrue and be capitalized to the principal amount of this Note (“PIK
Interest”), and shall thereafter be deemed to be a part of the principal amount of this
Note, unless such interest is paid in cash on or prior to the maturity date of this Note, as provide in Section 6 hereof. All PIK Interest
that has accrued and has not been paid in cash shall be payable in cash on the maturity date provided in Section 6 hereof.

 

3.
Default Rate. Upon the occurrence of an Event of Default (as defined herein) under this Note, interest shall accrue on all
outstanding principal at a rate equal to the Interest Rate plus one percent (1%) per annum (the “Default Rate”).

 

4.
Prepayment. This Note may not be prepaid by the Company without the prior written consent of the Payee.

 

5.
Priority. This Note shall rank senior to any and all other loans, advances, debts, liabilities, obligations, covenants and
duties of Obligor.

 

6.
Maturity Date. This Note shall become due and payable in lawful money of the United States of America, and in any event the
outstanding principal balance and accrued interest hereunder together with any additional amounts payable hereunder shall be due on earlier
of (i) the consummation of the first underwritten public offering (the “IPO”)
of Obligor pursuant to an effective registration statement under the Securities Act of 1933, as amended, covering the offer and sale
by Obligor of not less than $10,000,000 of its equity securities, as a result of or following which Obligor shall be a reporting issuer
under the Securities and Exchange Act of 1934, as amended, and its common stock (the “Common Stock”) shall
be listed on the Nasdaq Stock Market, and (ii) twelve months from the funding of the Principal to Obligor.

 

7.
Conversion Right.

 

(a)
Conversion at Option of Payee.

 

(i)
This Note shall be convertible into shares of Common Stock at the option of the Payee, in whole or in part at any time and from time
to time, after the date of this Note (subject to the limitations on conversion set forth in Section 7(b) hereof). The number of shares
of Common Stock issuable upon a conversion hereunder equals the quotient obtained by dividing (x) the outstanding amount of this Note
to be converted by (y) the Conversion Price (as defined in Section 7(c)(i)). Obligor shall deliver Common Stock certificates to the Payee
prior to the fifth (5th) trading day after a Conversion Date.

 

(ii)
The Payee shall effect conversions by delivering to Obligor a completed notice in the form attached hereto as Exhibit A (a “Conversion
Notice”). The date on which a Conversion Notice is delivered is the “Conversion Date.” Unless the Payee
is converting the entire principal and interest amount outstanding under this Note, the Payee is not required to physically surrender
this Note to Obligor in order to effect conversions. Conversions hereunder shall have the effect of lowering the outstanding principal
amount of this Note plus all accrued and unpaid interest thereon in an amount equal to the applicable conversion. The Payee and Obligor
shall maintain records showing the principal amount converted and the date of such conversions. In the event of any dispute or discrepancy,
the records of the Payee shall be controlling and determinative in the absence of manifest error.

 

    	2

     

    

 

(b)
Certain Conversion Restrictions.

 

(i)
Obligor shall not effect any conversions of this Note and the Payee shall not have the right to convert any portion of this Note or receive
shares of Common Stock as payment of interest hereunder to the extent that after giving effect to such conversion or receipt of such
interest payment, the Payee, together with any affiliate thereof, would beneficially own (as determined in accordance with Section 13(d)
of the Exchange Act and the rules promulgated thereunder) in excess of 9.99% of the number of shares of Common Stock outstanding immediately
after giving effect to such conversion or receipt of shares as payment of interest. Since the Payee will not be obligated to report to
Obligor the number of shares of Common Stock it may hold at the time of a conversion hereunder, unless the conversion at issue would
result in the issuance of shares of Common Stock in excess of 9.99% of the then outstanding shares of Common Stock without regard to
any other shares which may be beneficially owned by the Payee or an affiliate thereof, the Payee shall have the authority and obligation
to determine whether the restriction contained in this Section will limit any particular conversion hereunder and to the extent that
the Payee determines that the limitation contained in this Section applies, the determination of which portion of the principal amount
of this Note is convertible shall be the responsibility and obligation of the Payee. If the Payee has delivered a Conversion Notice for
a principal amount of this Note that, without regard to any other shares that the Payee or its affiliates may beneficially own, would
result in the issuance in excess of the permitted amount hereunder, Obligor shall notify the Payee of this fact and shall honor the conversion
for the maximum principal amount permitted to be converted on such Conversion Date in accordance with the periods described herein and,
any principal amount tendered for conversion in excess of the permitted amount hereunder shall remain outstanding under this Note. The
provisions of this Section may be waived by a Payee (but only as to itself and not to any other Payee) upon not less than 65 days prior
notice to Obligor only upon an Event of Default. Other Payees shall be unaffected by any such waiver.

 

(c)
Conversion Price and Adjustments to Conversion Price.

 

(i)
The conversion price in effect on any Conversion Date shall be equal to 80% of the offering price per share of common stock in the IPO
(the “Conversion Price”). The Conversion Price may be adjusted pursuant to the terms of this Note. In the event that
the IPO is not consummated within 12 months of the date of this Note, then the Conversion Price shall be equal to 65% of the offering
price per share of common stock in the IPO. In the event that the IPO is not consummated within 24 months of the date of this Note, then
the Conversion Price shall be equal to 50% of the offering price per share of common stock in the IPO.

 

    	3

     

    

 

(ii)
If Obligor, at any time while this Note is outstanding, shall (a) pay a stock dividend or otherwise make a distribution or distributions
on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock, (b) subdivide outstanding
shares of Common Stock into a larger number of shares, (c) combine (including by way of reverse stock split) outstanding shares of Common
Stock into a smaller number of shares, or (d) issue by reclassification of shares of the Common Stock any shares of capital stock of
Obligor, then the Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock
(excluding treasury shares, if any) outstanding before such event and of which the denominator shall be the number of shares of Common
Stock outstanding after such event. Any adjustment made pursuant to this Section shall become effective immediately after the record
date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after
the effective date in the case of a subdivision, combination or re-classification.

 

(iii)
If Obligor, at any time while this Note is outstanding, shall issue rights, options or warrants to all holders of Common Stock (and not
to the Payee) entitling them to subscribe for or purchase shares of Common Stock at a price per share less than the Conversion Price,
then the Conversion Price shall be multiplied by a fraction, of which the denominator shall be the number of shares of the Common Stock
(excluding treasury shares, if any) outstanding on the date of issuance of such rights or warrants (plus the number of additional shares
of Common Stock offered for subscription or purchase), and of which the numerator shall be the number of shares of the Common Stock (excluding
treasury shares, if any) outstanding on the date of issuance of such rights or warrants, plus the number of shares which the aggregate
offering price of the total number of shares so offered would purchase at the Conversion Price. Such adjustment shall be made whenever
such rights or warrants are issued, and shall become effective immediately after the record date for the determination of stockholders
entitled to receive such rights, options or warrants. However, upon the expiration of any such right, option or warrant to purchase shares
of the Common Stock the issuance of which resulted in an adjustment in the Conversion Price pursuant to this Section, if any such right,
option or warrant shall expire and shall not have been exercised, the Conversion Price shall immediately upon such expiration be recomputed
and effective immediately upon such expiration be increased to the price which it would have been (but reflecting any other adjustments
in the Conversion Price made pursuant to the provisions of this Section after the issuance of such rights or warrants) had the adjustment
of the Conversion Price made upon the issuance of such rights, options or warrants been made on the basis of offering for subscription
or purchase only that number of shares of the Common Stock actually purchased upon the exercise of such rights, options or warrants actually
exercised.

 

(iv)
If Obligor, at any time while this Note is outstanding, shall distribute to all holders of Common Stock (and not to the Payee) evidence
of its indebtedness or assets or rights or warrants to subscribe for or purchase any security, then in each such case the Conversion
Price at which this Note shall thereafter be convertible shall be determined by multiplying the Conversion Price in effect immediately
prior to the record date fixed for determination of stockholders entitled to receive such distribution by a fraction of which the denominator
shall be the Closing Bid Price determined as of the record date mentioned above, and of which the numerator shall be such Closing Bid
Price on such record date less the then fair market value at such record date of the portion of such assets or evidence of indebtedness
so distributed applicable to one outstanding share of the Common Stock as determined by the Board of Directors in good faith. In either
case the adjustments shall be described in a statement provided to the Payee of the portion of assets or evidences of indebtedness so
distributed or such subscription rights applicable to one share of Common Stock. Such adjustment shall be made whenever any such distribution
is made and shall become effective immediately after the record date mentioned above. “Closing Bid Price” shall mean
the price per share in the last reported trade of the Common Stock of Obligor on the exchange or other market which the Common Stock
of Obligor is then listed as quoted by Bloomberg, LP.

 

    	4

     

    

 

(v)
In case of any reclassification of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is converted
into other securities, cash or property, the Payee shall have the right thereafter to, at its option, (A) convert the then outstanding
principal amount, together with all accrued but unpaid interest and any other amounts then owing hereunder in respect of this Note into
the shares of stock and other securities, cash and property receivable upon or deemed to be held by holders of the Common Stock following
such reclassification or share exchange, and the Payee of this Note shall be entitled upon such event to receive such amount of securities,
cash or property as the shares of the Common Stock of Obligor into which the then outstanding principal amount, together with all accrued
but unpaid interest and any other amounts then owing hereunder in respect of this Note could have been converted immediately prior to
such reclassification or share exchange would have been entitled, or (B) require Obligor to prepay the outstanding principal amount of
this Note, plus all interest and other amounts due and payable thereon. The entire prepayment price shall be paid in cash. This provision
shall similarly apply to successive reclassifications or share exchanges.

 

(vi)
Whenever the Conversion Price is adjusted pursuant to Section 3 hereof, Obligor shall promptly mail to the Payee a notice setting
forth the Conversion Price after such adjustment and setting forth a brief statement of the facts requiring such adjustment.

 

(vii)
If (A) Obligor shall declare a dividend (or any other distribution) on the Common Stock; (B) Obligor shall declare a special nonrecurring
cash dividend on or a redemption of the Common Stock; (C) Obligor shall authorize the granting to all holders of the Common Stock rights
or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights; (D) the approval of any stockholders
of Obligor shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which Obligor
is a party, any sale or transfer of all or substantially all of the assets of Obligor, of any compulsory share exchange whereby the Common
Stock is converted into other securities, cash or property; or (E) Obligor shall authorize the voluntary or involuntary dissolution,
liquidation or winding up of the affairs of Obligor; then, in each case, Obligor shall cause to be filed at each office or agency maintained
for the purpose of conversion of this Note, and shall cause to be mailed to the Payee at its last address as it shall appear upon the
stock books of Obligor, at least twenty (20) calendar days prior to the applicable record or effective date hereinafter specified, a
notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants,
or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer
or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock
of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such
reclassification, consolidation, merger, sale, transfer or share exchange, provided, that the failure to mail such notice or any defect
therein or in the mailing thereof shall not affect the validity of the corporate action required to be specified in such notice. The
Payee is entitled to convert this Note during the 20-day calendar period commencing the date of such notice to the effective date of
the event triggering such notice.

 

    	5

     

    

 

(viii)
In case of any (1) merger or consolidation of Obligor or any subsidiary of Obligor with or into another entity or person, or (2) sale
by Obligor or any subsidiary of Obligor of more than one-half of the assets of Obligor in one or a series of related transactions, a
Payee shall have the right to (A) exercise any rights under Section 2(b), (B) convert the aggregate amount of this Note then outstanding
into the shares of stock and other securities, cash and property receivable upon or deemed to be held by Payees of Common Stock following
such merger, consolidation or sale, and such Payee shall be entitled upon such event or series of related events to receive such amount
of securities, cash and property as the shares of Common Stock into which such aggregate principal amount of this Note could have been
converted immediately prior to such merger, consolidation or sales would have been entitled, or (C) in the case of a merger or consolidation,
require the surviving entity to issue to the Payee a convertible Note with a principal amount equal to the aggregate principal amount
of this Note then held by such Payee, plus all accrued and unpaid interest and other amounts owing thereon, which such newly issued convertible
Note shall have terms identical (including with respect to conversion) to the terms of this Note, and shall be entitled to all of the
rights and privileges of the Payee of this Note set forth herein and the agreements pursuant to which this Notes were issued. In the
case of clause (C), the conversion price applicable for the newly issued shares of convertible preferred stock or convertible Notes shall
be based upon the amount of securities, cash and property that each share of Common Stock would receive in such transaction and the Conversion
Price in effect immediately prior to the effectiveness or closing date for such transaction. The terms of any such merger, sale or consolidation
shall include such terms so as to continue to give the Payee the right to receive the securities, cash and property set forth in this
Section upon any conversion or redemption following such event. This provision shall similarly apply to successive such events.

 

(d)
Other Provisions.

 

(i)
Obligor shall at all times reserve and keep available out of its authorized Common Stock the full number of shares of Common Stock issuable
upon conversion of all outstanding amounts under this Note; and within three (3) business days following the receipt by Obligor of a
Payee’s notice that such minimum number of Underlying Shares is not so reserved, Obligor shall promptly reserve a sufficient number
of shares of Common Stock to comply with such requirement.

 

(ii)
All calculations under this Section 7 shall be rounded up to the nearest $0.0001 or whole share.

 

(iii)
Obligor covenants that it will at all times reserve and keep available out of its authorized and unissued shares of Common Stock solely
for the purpose of issuance upon conversion of this Note and payment of interest on this Note, each as herein provided, free from preemptive
rights or any other actual contingent purchase rights of persons other than the Payee, not less than such number of shares of the Common
Stock as shall (subject to any additional requirements of Obligor as to reservation of such shares set forth in this Note) be issuable
(taking into account the adjustments and restrictions set forth herein) upon the conversion of the outstanding principal amount of this
Note and payment of interest hereunder. Obligor covenants that all shares of Common Stock that shall be so issuable shall, upon issue,
be duly and validly authorized, issued and fully paid, nonassessable.

 

    	6

     

    

 

(iv)
Upon a conversion hereunder Obligor shall not be required to issue stock certificates representing fractions of shares of the Common
Stock, but may if otherwise permitted, make a cash payment in respect of any final fraction of a share based on the Closing Bid Price
at such time. If Obligor elects not, or is unable, to make such a cash payment, the Payee shall be entitled to receive, in lieu of the
final fraction of a share, one whole share of Common Stock.

 

(v)
The issuance of certificates for shares of the Common Stock on conversion of this Note shall be made without charge to the Payee thereof
for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such certificate, provided that
Obligor shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance and delivery of
any such certificate upon conversion in a name other than that of the Payee of such Note so converted and Obligor shall not be required
to issue or deliver such certificates unless or until the person or persons requesting the issuance thereof shall have paid to Obligor
the amount of such tax or shall have established to the satisfaction of Obligor that such tax has been paid.

 

(vi)
Nothing herein shall limit a Payee’s right to pursue actual damages or declare an Event of Default herein for Obligor ‘s
failure to deliver certificates representing shares of Common Stock upon conversion within the period specified herein and such Payee
shall have the right to pursue all remedies available to it at law or in equity including, without limitation, a decree of specific performance
and/or injunctive relief, in each case without the need to post a bond or provide other security. The exercise of any such rights shall
not prohibit the Payee from seeking to enforce damages pursuant to any other Section hereof or under applicable law.

 

8.
Cancellation of Note. Upon payment in full of all principal and interest payable hereunder, this Note shall be surrendered
to Obligor for cancellation.

 

9.
Events of Default. Any of the following events which shall occur shall constitute an “Event of Default”:

 

a.
Obligor shall fail to pay when due any amount of principal or interest hereunder or other amount payable hereunder, where such failure
continues for five (5) days after receipt of written notice from Payee specifying such failure;

 

b.
Any representation or warranty made or furnished by or on behalf of Obligor to Payee in writing in connection with this Note or the Purchase
Agreement shall be false, incorrect, incomplete or misleading in any material respect when made or furnished; or

 

c.
Obligor becomes insolvent or the subject of any bankruptcy or other voluntary or involuntary proceeding, in or out of court, for the
adjustment of debtor-creditor relationships (“Insolvency Proceeding”); and, in the case of an involuntary Insolvency
Proceeding, such Insolvency Proceeding is not dismissed within ninety (90) days after filing.

 

Upon
the occurrence of any Event of Default, the outstanding principal balance and accrued interest hereunder together with any additional
amounts payable hereunder shall be immediately due and payable without demand or notice of any kind, this Note will bear interest at
the Default Rate from the date of the occurrence of the Event of Default, and Payee may exercise from time to time any of the rights
and remedies available under this Note or under applicable law.

 

    	7

     

    

 

10.
Time is of the Essence. Time is of the essence in the performance of this Note.

 

11.
Waivers. Obligor waives presentment, demand for performance, notice of nonperformance, protest, notice of protest, and notice
of dishonor. No delay on the part of Payee in exercising any right hereunder shall operate as a waiver of such right under this Note.

 

12.
Fees and Costs. If the Indebtedness presented by this Note or any part thereof is collected at law or in equity or in bankruptcy,
receivership or other judicial proceedings or if this Note is placed in the hands of attorneys for collection after default, Obligor
agrees to pay, in addition to the principal and interest payable thereon, reasonable attorneys’ fees and costs incurred by Payee.

 

13.
Amendments and Waivers. No amendment or waiver of any provision of the Note, nor consent to any departure by Obligor therefrom,
shall be effective unless the same shall be in writing and signed by the Payee and the Obligor, and then such waiver or consent shall
be effective only in the specific instance and for the specific purpose for which given. Any amendment or waiver effected in accordance
with this paragraph shall be binding upon Obligor, Payee and each transferee of this Note.

 

14.
Notices. Any notice or other communication (except payment) required or permitted hereunder shall be in writing and shall
be deemed to have been given upon delivery if personally delivered or three business days following deposit if deposited in the United
States mail for mailing by certified mail, postage prepaid, and addressed as follows:

 

	 	If to Payee:	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	If to Obligor:	Opti-Harvest, Inc.	 
	 	 	1801 Century Park East, Suite 520	 
	 	 	Los Angeles, California 90067	 

 

Any
payment shall be deemed made upon receipt by Payee. Each of the above addressees may change its address for purposes of this paragraph
by giving to the other addressee notice of such new address in conformance with this paragraph.

 

15.
Usury. Notwithstanding anything herein to the contrary, payment of any interest, expense or other amount shall not be required
if such payment would be unlawful. In any such event, the note shall automatically be deemed amended so that interest charges and all
other payments required hereunder, individually and in the aggregate, shall be equal to but not greater than the maximum permitted by
law.

 

    	8

     

    

 

16.
Further Assurances. Each party shall execute, acknowledge, deliver, file, notarize and register (at its own expense) all documents,
instruments, certificates, agreements and assurances and provide all information and take or forbear from all such action as the other
party may reasonably deem necessary or appropriate to achieve the purposes of this Note or satisfy the Obligations hereunder.

 

17.
Severability. Whenever possible, each provision of this Note shall be interpreted in such manner as to be effective and valid
under all applicable laws and regulations. If, however, any provision of this Note shall be prohibited by or be invalid under any such
law or regulation in any jurisdiction, it shall, as to such jurisdiction, be deemed modified to conform to the minimum requirements of
such law or regulation, or, if for any reason it is not deemed so modified, it shall be ineffective and invalid only to the extent of
such prohibition or invalidity without affecting the remaining provisions of this Note, or the validity or effectiveness of such provision
in any other jurisdiction.

 

18.
Construction. This Note is the result of negotiations among, and has been reviewed by, the Obligor, the Payee and their respective
counsel. Accordingly, this Note shall be deemed to be the product of all parties hereto, and no ambiguity shall be construed in favor
of or against the Obligor or the Payee.

 

19.
Governing Law and Jurisdiction. This Note and all actions arising out of or in connection with this Note shall be governed
by and construed in accordance with the internal laws of the State of New York, without regard to the conflicts of law rules of the State
of New York or of any other jurisdiction.

 

(Signature
Page Follows)

 

    	9

     

    

 

IN
WITNESS WHEREOF, Obligor has executed this Senior Secured
Promissory Note as of the date first written above.

 

	 	Obligor:
	 	 
	 	OPTI-HARVEST,
    INC.

 

	 	By:	
	 	Name:	Jonathan
    Destler
	 	Title:	Chief
    Executive Officer

 

    	10

     

    

 

EXHIBIT
A

 

CONVERSION
NOTICE

 

(To
be executed by the Payee in order to Convert the Note)

 

TO:
Opti-Harvest, Inc.

 

The
undersigned hereby irrevocably elects to convert $ of he principal amount of that certain Senior Convertible Promissory Note dated __________,
2021, in the principal amount of $______ into Shares of Common Stock of Opti-Harvest, Inc., according to the conditions stated
therein, as of the Conversion Date written below.

 

	Conversion
    Date:	
	Amount
    to be converted:	$
	Conversion
    Price:	$
	Number
    of shares of Common Stock to be issued:	
	Amount
                                            of Note Unconverted:
	$

 

Please
issue the shares of Common Stock in the following name and to the following address:

 

	Issue
    to:	 

	 	 
	 	 
	Authorized
    Signature:	
	Name:	
	Title:	
	Broker
    DTC Participant Code:	
	Account
    Number:	

 

    	11

     

    

 

EXHIBIT
C

 

FORM
OF WARRANT TO PURCHASE SHARES

 

WARRANT
TO PURCHASE SHARES

 

THIS
WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATE. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED
OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS IN ACCORDANCE WITH APPLICABLE REGISTRATION REQUIREMENTS
OR AN EXEMPTION THEREFROM. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE ISSUER THAT
SUCH OFFER, SALE, TRANSFER, PLEDGE OR HYPOTHECATION OTHERWISE COMPLIES WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS. THIS WARRANT
MUST BE SURRENDERED TO THE COMPANY OR ITS TRANSFER AGENT AS A CONDITION PRECEDENT TO THE SALE, TRANSFER, PLEDGE OR HYPOTHECATION OF ANY
INTEREST IN ANY OF THE SECURITIES REPRESENTED HEREBY.

 

	Purchase
                                            Price

    [Warrant
    Purchase Price]
	Dated
                                            as of __________, 2021

    Void
    after the date specified in Section 8

 

OPTI-HARVEST,
INC.

 

WARRANT
TO PURCHASE SHARES

 

No.
[Warrant Number]

 

THIS
CERTIFIES THAT, for value received, [Investor], or its registered assigns (the “Holder”), is entitled, subject to
the provisions and upon the terms and conditions set forth herein, to purchase from Opti-Harvest, Inc., a Delaware corporation
(the “Company”), Shares (as defined below), in the amounts, at such times and at the price per share set forth in
Section 1. The term “Warrant” as used herein shall include this Warrant and any warrants delivered in substitution
or exchange therefor as provided herein. This Warrant is issued in connection with the transactions described in the Note and Warrant
Purchase Agreement, dated as of ________________, 2021, by and among the Company and the Investors described therein (the “Note
and Warrant Purchase Agreement”). This Warrant is one of the series of “Warrants” issued pursuant to the Note and
Warrant Purchase Agreement. Capitalized terms not otherwise defined herein shall have the respective meanings ascribed to such terms
in the Note and Warrant Purchase Agreement and/or the form of subordinated convertible promissory note attached as Exhibit B to the Note
and Warrant Purchase Agreement (the “Note”, and together with each other Note issued pursuant to the Note and Warrant
Purchase Agreement, the “Notes”). The Holder of this Warrant is subject to certain restrictions as set forth in the
Note and Warrant Purchase Agreement.

 

    	12

     

    

 

The
following is a statement of the rights of the Holder and the conditions to which this Warrant is subject, and to which the Holder, by
acceptance of this Warrant, agrees:

 

1.
Number and Price of Shares; Exercise Period.

 

(a)
Definition of Shares. “Shares” shall mean the shares of Common Stock of the Company.

 

(b)
Number of Shares. Subject to any previous exercise of the Warrant, the Holder shall have the right to purchase up to the number
of Shares that equals the quotient obtained by dividing: (i) the Warrant Coverage Amount, by (ii) the Conversion Price,
prior to (or in connection with) the expiration of this Warrant as provided in Section 8.

 

(c)
Exercise Price. The exercise price per Share shall be equal to 115% of the offering price per share of common stock of the Company
in its first underwritten public offering (the “IPO”) pursuant to an
effective registration statement under the Securities Act of 1933, as amended, covering the offer and sale by the Company of not less
than $10,000,000 of its equity securities, as a result of or following which the Company shall be a reporting issuer under the Securities
and Exchange Act of 1934, as amended, and its common stock shall be listed on the Nasdaq Stock Market, subject to adjustment pursuant
hereto (the “Exercise Price”).

 

(d)
Exercise Period. This Warrant shall be exercisable, in whole or in part: (i) after the earlier to occur of: (A) the consummation
of the IPO; or (B) six months after the date of this Warrant; and (ii) prior to (or in connection with) the expiration of this Warrant
as set forth in Section 8.

 

(e)
Warrant Coverage Amount. The “Warrant Coverage Amount” shall mean the amount obtained by multiplying:
(A) one hundred percent (100%); by (B) aggregate principal amount of the Holder’s Note(s) delivered pursuant to the Note
and Warrant Purchase Agreement.

 

2.
Exercise of the Warrant.

 

(a)
Exercise. The purchase rights represented by this Warrant may be exercised at the election of the Holder, in whole or in part,
in accordance with Section 1, by:

 

(i)
the tender to the Company at its principal office (or such other office or agency as the Company may designate) of a notice of exercise,
in the form of Exhibit A hereto (the “Notice of Exercise”), duly completed and executed by or on behalf of
the Holder, together with the surrender of this Warrant; and

 

(ii)
the payment to the Company of an amount equal to: (A) the Exercise Price; multiplied by (B) the number of Shares being purchased,
by wire transfer or certified, cashier’s or other check acceptable to the Company and payable to the order of the Company.

 

    	13

     

    

 

(b)
Net Issue Exercise. If the Shares underlying this Warrant are not registered as part of the Company’s registration statement
the subject of its IPO and filed with the Securities and Exchange Commission within six months of the date of issuance of this Warrant,
then in lieu of exercising this Warrant pursuant to Section 2(a)(ii), if the fair market value of one Share is greater than the
Exercise Price (at the date of calculation as set forth below), the Holder may elect to receive a number of Shares equal to the value
of this Warrant (or of any portion of this Warrant being cancelled) by surrender of this Warrant at the principal office of the Company
(or such other office or agency as the Company may designate), together with a properly completed and executed Notice of Exercise reflecting
such election, in which event the Company shall issue to the Holder that number of Shares computed using the following formula:

 

	 	 	X
    	 	=
    	 	   Y
    (A – B)    	 
	 	 	 	A	 

 

Where:

 

	 	X	=	The
    number of Shares to be issued to the Holder.
	 	 	 	 
	 	Y	=	The
    number of Shares purchasable under this Warrant or, if only a portion of the Warrant is being exercised, the portion of the Warrant
    being cancelled (at the date of such calculation).
	 	 	 	 
	 	A	=	The
    fair market value of one Share (at the date of such calculation).
	 	 	 	 
	 	B	=	The
    Exercise Price (as adjusted to the date of such calculation).

 

For
purposes of the calculation above, the fair market value of one Share shall be determined by the Board of Directors of the Company, acting
in good faith; provided, however, that:

 

(i)
where a public market exists for the Company’s common stock at the time of such exercise, the fair market value per Share shall
be the product of: (A) the average of the closing bid prices of the Common Stock or the closing price quoted on the national securities
exchange on which the Common Stock is listed as published in the Wall Street Journal, as applicable, for the ten (10) trading
day period ending five (5) trading days prior to the date of determination of the fair market value; and (B) the number of shares of
Common Stock into which each Share is convertible at the time of such exercise, as applicable; and

 

(ii)
if the Warrant is exercised in connection with the Company’s initial public offering of Common Stock, the fair market value per
Share shall be the product of: (A) the per share offering price to the public of the Company’s initial public offering; and (B)
the number of shares of Common Stock into which each Share is convertible at the time of such exercise, as applicable.

 

(c)
Stock Certificates. The rights under this Warrant shall be deemed to have been exercised and the Shares issuable upon such exercise
shall be deemed to have been issued immediately prior to the close of business on the date this Warrant is exercised in accordance with
its terms, and the person entitled to receive the Shares issuable upon such exercise shall be treated for all purposes as the holder
of record of such Shares as of the close of business on such date. As promptly as reasonably practicable on or after such date, the Company
shall issue and deliver to the person or persons entitled to receive the same a certificate or certificates for that number of Shares
issuable upon such exercise. In the event that the rights under this Warrant are exercised in part and have not expired, the Company
shall execute and deliver a new Warrant reflecting the number of Shares that remain subject to this Warrant.

 

    	14

     

    

 

(d)
No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of the rights under this Warrant. In lieu of such fractional share to which the Holder would otherwise be entitled, the Company shall
make a cash payment equal to the Exercise Price multiplied by such fraction of a share.

 

(e)
Conditional Exercise. The Holder may exercise this Warrant conditioned upon (and effective immediately prior to) consummation
of any transaction that would cause the expiration of this Warrant pursuant to Section 8 by so indicating in the Notice of Exercise.

 

(f)
Automatic Exercise Upon Change of Control. To the extent this Warrant is not previously exercised and if the Company will consummate
a Change of Control, this Warrant shall be deemed automatically exercised in accordance with Section 2(b) above (even if not surrendered)
immediately prior to the consummation of such Change of Control; provided, however, that the Holder may, at the Holder’s
option, elect to exercise this Warrant in accordance with Section 2(a) above prior to the Company’s consummation of such
Change of Control. To the extent this Warrant or any portion thereof is deemed automatically exercised pursuant to this Section 2(f),
the Company (or its successor entity) agrees to notify the Holder within a reasonable period of time of the number of Shares, if any
(or the consideration payable for such number of Shares in connection with such Change of Control, if any), that the Holder is entitled
to receive by reason of such automatic exercise. If applicable, the Company shall not be required to deliver any stock certificate(s)
evidencing any Shares issuable upon such automatic exercise unless and until the Company has received the original of this Warrant. The
Company shall provide the Holder with prior notice of the Company’s contemplated consummation of any such Change of Control in
accordance with Section 7 below.

 

(g)
Reservation of Stock. The Company agrees during the term the rights under this Warrant are exercisable to take all reasonable
action to reserve and keep available from its authorized and unissued shares of Preferred Stock for the purpose of effecting the exercise
of this Warrant such number of shares (and shares of Common Stock for issuance on conversion of such shares) as shall from time to time
be sufficient to effect the exercise of the rights under this Warrant; and if at any time the number of authorized but unissued shares
of Preferred Stock (and shares of Common stock for issuance upon conversion of such shares) shall not be sufficient for purposes of the
exercise of this Warrant in accordance with its terms and the conversion of the Shares, without limitation of such other remedies as
may be available to the Holder, the Company will use reasonable efforts to take such corporate action as may, in the opinion of counsel,
be necessary to increase its authorized and unissued shares of its Preferred Stock (and shares of Common Stock for issuance on conversion
of such shares) to a number of shares as shall be sufficient for such purposes.

 

3.
Replacement of the Warrant. Subject to the receipt of evidence reasonably satisfactory to the Company of the loss, theft,
destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, upon delivery of an indemnity agreement reasonably
satisfactory in form and substance to the Company or, in the case of mutilation, upon surrender and cancellation of this Warrant, the
Company at the expense of the Holder shall execute and deliver, in lieu of this Warrant, a new warrant of like tenor and amount.

 

    	15

     

    

 

4.
Transfer of the Warrant.

 

(a)
Warrant Register. The Company shall maintain a register (the “Warrant Register”) containing the name and address
of the Holder or Holders. Until this Warrant is transferred on the Warrant Register in accordance herewith, the Company may treat the
Holder as shown on the Warrant Register as the absolute owner of this Warrant for all purposes, notwithstanding any notice to the contrary.
Any Holder of this Warrant (or of any portion of this Warrant) may change its address as shown on the Warrant Register by written notice
to the Company requesting such a change of address.

 

(b)
Warrant Agent. The Company may appoint an agent for the purpose of maintaining the Warrant Register referred to in Section
4(a), issuing the Shares or other securities then issuable upon the exercise of the rights under this Warrant, exchanging this Warrant,
replacing this Warrant or conducting related activities.

 

(c)
Transferability of the Warrant. Subject to the provisions of this Warrant with respect to compliance with the Securities Act and
limitations on assignments and transfers, including, without limitation, compliance with the restrictions on transfer set forth in Section
5, title to this Warrant may be transferred by endorsement (by the transferor and the transferee executing the assignment form, attached
hereto as Exhibit B (the “Assignment Form”)), and delivery in the same manner as a negotiable instrument transferable
by endorsement and delivery.

 

(d)
Exchange of the Warrant upon a Transfer. On surrender of this Warrant (and a properly endorsed Assignment Form) for exchange,
subject to the provisions of this Warrant with respect to compliance with the Securities Act and limitations on assignments and transfers,
the Company shall issue to or on the order of the Holder a new warrant or warrants of like tenor, in the name of the Holder or as the
Holder (on payment by the Holder of any applicable transfer taxes) may direct, for the number of Shares issuable upon exercise hereof,
and the Company shall register any such transfer upon the Warrant Register. This Warrant (and the securities issuable upon exercise of
the rights under this Warrant) must be surrendered to the Company or its warrant or transfer agent, as applicable, as a condition precedent
to the sale, pledge, hypothecation or other transfer of any interest in any of the securities represented hereby.

 

(e)
Taxes. In no event shall the Company be required to pay any tax which may be payable in respect of any transfer involved in the
issue and delivery of any certificate in a name other than that of the Holder, and the Company shall not be required to issue or deliver
any such certificate unless and until the person or persons requesting the issue thereof shall have paid to the Company the amount of
such tax or shall have established to the satisfaction of the Company that such tax has been paid or is not payable.

 

5.
Restrictions on Transfer of the Warrant and Shares; Compliance with Securities Laws. By acceptance of this Warrant, the
Holder agrees to comply with the following:

 

(a)
Restrictions on Transfers. Subject to Section 5(b) below, this Warrant may not be transferred or assigned, in whole or
in part, without the Company’s prior written consent (which shall not be unreasonably withheld), and any attempt by the Holder
to transfer or assign any rights, duties or obligations that arise under this Warrant without such permission shall be void. Any transfer
of this Warrant or the Shares or the shares of Common Stock issuable upon conversion of the Shares (the “Securities”)
must be in compliance with all applicable federal and state securities laws. The Holder agrees not to make any sale, assignment, transfer,
pledge or other disposition of all or any portion of the Securities, or any beneficial interest therein, unless and until the transferee
thereof has agreed in writing for the benefit of the Company to take and hold such Securities subject to, and to be bound by, the terms
and conditions set forth in this Warrant to the same extent as if the transferee were the original Holder hereunder, and

 

    	16

     

    

 

(i)
there is then in effect a registration statement under the Securities Act covering such proposed disposition and such disposition is
made in accordance with such registration statement, or

 

(ii)(A)
such Holder shall have given prior written notice to the Company of such Holder’s intention to make such disposition and shall
have furnished the Company with a detailed description of the manner and circumstances of the proposed disposition, (B) the transferee
shall have confirmed to the satisfaction of the Company in writing, in substantially the form of Exhibit A-1 hereto, that the
Securities are being acquired (1) solely for the transferee’s own account and not as a nominee for any other party, (2) for investment
and (3) not with a view toward distribution or resale, and shall have confirmed such other matters related thereto as may be reasonably
requested by the Company, and (C) if requested by the Company, such Holder shall have furnished the Company, at the Holder’s expense,
with evidence satisfactory to the Company that such disposition will not require registration of such Securities under the Securities
Act, whereupon such Holder shall be entitled to transfer such Securities in accordance with the terms of the notice delivered by such
Holder to the Company. The Company agrees that it will not require an opinion of counsel for a transfer pursuant to Rule 144 of the Securities
Act except in unusual circumstances.

 

(b)
Permitted Transfers. The following transfers shall not be subject to Section 5(a): (i) a transfer not involving a change
in beneficial ownership; or (ii) transactions involving the distribution without consideration of Securities by any Holder to: (A) a
parent, subsidiary or other affiliate of a Holder that is a corporation, (B) any of the Holder’s partners, members or other equity
owners, or retired partners or members, or to the estate of any of its partners, members or other equity owners or retired partners or
members, or (C) a venture capital fund that is controlled by or under common control with one or more general partners or managing members
of, or shares the same management company with, the Holder; provided, however, in each case, that the Holder shall give
written notice to the Company of the Holder’s intention to effect such disposition and shall have furnished the Company with a
detailed description of the manner and circumstances of the proposed disposition.

 

(c)
Investment Representation Statement. Unless the rights under this Warrant are exercised pursuant to an effective registration
statement under the Securities Act that includes the Shares with respect to which the Warrant was exercised, it shall be a condition
to any exercise of the rights under this Warrant that the Holder shall have confirmed to the satisfaction of the Company in writing,
in substantially the form of Exhibit A-1 hereto, that the Shares so purchased are being acquired solely for the Holder’s
own account and not as a nominee for any other party, for investment and not with a view toward distribution or resale and that the Holder
shall have confirmed such other matters related thereto as may be reasonably requested by the Company.

 

    	17

     

    

 

(d)
Securities Law Legend. The Securities shall (unless otherwise permitted by the provisions of this Warrant) be stamped or imprinted
with a legend substantially similar to the following (in addition to any legend required by state securities laws):

 

THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR
UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED
EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS IN ACCORDANCE WITH APPLICABLE REGISTRATION REQUIREMENTS OR AN
EXEMPTION THEREFROM. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE ISSUER THAT SUCH
OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION OTHERWISE COMPLIES WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS. THIS CERTIFICATE
MUST BE SURRENDERED TO THE COMPANY OR ITS TRANSFER AGENT AS A CONDITION PRECEDENT TO THE SALE, TRANSFER, PLEDGE OR HYPOTHECATION OF ANY
INTEREST IN ANY OF THE SECURITIES REPRESENTED HEREBY.

 

(e)
Market Stand-off Legend. The Shares and Common Stock issued upon exercise hereof or conversion thereof shall also be stamped or
imprinted with a legend in substantially the following form:

 

THE
SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE, INCLUDING A LOCK-UP PERIOD IN THE EVENT
OF A PUBLIC OFFERING, AS SET FORTH IN THE WARRANT PURSUANT TO WHICH THESE SHARES WERE ISSUED, A COPY OF WHICH MAY BE OBTAINED AT THE
PRINCIPAL OFFICE OF THE COMPANY.

 

(f)
Instructions Regarding Transfer Restrictions. The Holder consents to the Company making a notation on its records and giving instructions
to any transfer agent in order to implement the restrictions on transfer established in this Section 5.

(g)
Removal of Legend. The legend referring to federal and state securities laws identified in Section 5(c) stamped on a certificate
evidencing the Shares (and the Common Stock issuable upon conversion thereof) and the stock transfer instructions and record notations
with respect to such securities shall be removed and the Company shall issue a certificate without such legend to the holder of such
securities if: (i) such securities are registered under the Securities Act; or (ii) such holder provides the Company with an opinion
of counsel reasonably acceptable to the Company to the effect that a sale or transfer of such securities may be made without registration
or qualification.

 

    	18

     

    

 

6.
Adjustments. Subject to the expiration of this Warrant pursuant to Section 8, the number and kind of Shares purchasable
hereunder and the Exercise Price therefor are subject to adjustment from time to time, as follows:

 

(a)
Merger or Reorganization. If at any time there shall be any reorganization, recapitalization, merger or consolidation (a “Reorganization”)
involving the Company (other than as otherwise provided for herein or as would cause a deemed net exercise pursuant to Section 2(f))
in which shares of the Company’s stock are converted into or exchanged for securities, cash or other property, then, as a part
of such Reorganization, lawful provision shall be made so that the Holder shall thereafter be entitled to receive upon exercise of this
Warrant, the kind and amount of securities, cash or other property of the successor corporation resulting from such Reorganization, equivalent
in value to that which a holder of the Shares deliverable upon exercise of this Warrant would have been entitled in such Reorganization
if the right to purchase the Shares hereunder had been exercised immediately prior to such Reorganization. In any such case, appropriate
adjustment (as determined in good faith by the Board of Directors of the successor corporation) shall be made in the application of the
provisions of this Warrant with respect to the rights and interests of the Holder after such Reorganization to the end that the provisions
of this Warrant shall be applicable after the event, as near as reasonably may be, in relation to any shares or other securities deliverable
after that event upon the exercise of this Warrant.

 

(b)
Reclassification of Shares. If the Securities issuable upon exercise of this Warrant are changed into the same or a different
number of securities of any other class or classes by reclassification, capital reorganization, conversion of all outstanding shares
of the relevant class or series (other than as would cause the expiration of this Warrant pursuant to Section 8) or otherwise
(other than as otherwise provided for herein) (a “Reclassification”), then, in any such event, in lieu of the number
of Shares which the Holder would otherwise have been entitled to receive, the Holder shall have the right thereafter to exercise this
Warrant for a number of shares of such other class or classes of stock that a holder of the number of Securities deliverable upon exercise
of this Warrant immediately before that change would have been entitled to receive in such Reclassification, all subject to further adjustment
as provided herein with respect to such other shares.

 

(c)
Subdivisions and Combinations. In the event that the outstanding shares of the Securities issuable upon exercise of this Warrant
are subdivided (by stock split, by payment of a stock dividend or otherwise) into a greater number of shares of such Securities, the
number of Shares issuable upon exercise of the rights under this Warrant immediately prior to such subdivision shall, concurrently with
the effectiveness of such subdivision, be proportionately increased, and the Exercise Price shall be proportionately decreased, and in
the event that the outstanding shares of the Securities issuable upon exercise of this Warrant are combined (by reclassification or otherwise)
into a lesser number of shares of such Securities, the number of Shares issuable upon exercise of the rights under this Warrant immediately
prior to such combination shall, concurrently with the effectiveness of such combination, be proportionately decreased, and the Exercise
Price shall be proportionately increased.

 

(d)
Notice of Adjustments. Upon any adjustment in accordance with this Section 6, the Company shall give notice thereof to
the Holder, which notice shall state the event giving rise to the adjustment, the Exercise Price as adjusted and the number of securities
or other property purchasable upon the exercise of the rights under this Warrant, setting forth in reasonable detail the method of calculation
of each. The Company shall, upon the written request of any Holder, furnish or cause to be furnished to such Holder a certificate setting
forth: (i) such adjustments; (ii) the Exercise Price at the time in effect; and (iii) the number of securities and the amount, if any,
of other property that at the time would be received upon exercise of this Warrant.

 

    	19

     

    

 

7.
Notification of Certain Events. Prior to the expiration of this Warrant pursuant to Section 8, in the event that
the Company shall authorize:

 

(a)
the issuance of any dividend or other distribution on the capital stock of the Company (other than: (i) dividends or distributions otherwise
provided for in Section 6; (ii) repurchases of Common Stock issued to or held by employees, officers, directors or consultants
of the Company or its subsidiaries upon termination of their employment or services pursuant to agreements providing for the right of
said repurchase; (iii) repurchases of Common Stock issued to or held by employees, officers, directors or consultants of the Company
or its subsidiaries pursuant to rights of first refusal or first offer contained in agreements providing for such rights; or (iv) repurchases
of capital stock of the Company in connection with the settlement of disputes with any stockholder), whether in cash, property, stock
or other securities;

 

(b)
the voluntary liquidation, dissolution or winding up of the Company;

 

(c)
a Change of Control; or

 

(d)
any transaction resulting in the expiration of this Warrant pursuant to Section 8(b).

 

the
Company shall send to the Holder of this Warrant at least ten (10) calendar days prior written notice of the date on which a record shall
be taken for any such dividend or distribution specified in clause (a) or the expected effective date of any such other event specified
in clause (b), (c) or (d), as applicable. The notice provisions set forth in this Section 7 may be shortened or waived prospectively
or retrospectively by the consent of the holders of greater than fifty percent (50%) of the aggregate Warrant Coverage Amount of all
Warrants issued pursuant to the Note and Warrant Purchase Agreement (a “Majority in Interest of Warrant Holders”).

 

8.
Expiration of the Warrant. This Warrant shall expire and shall no longer be exercisable as of 5:00 p.m., Pacific time,
on ______________, 2024.

 

9.
No Rights as a Stockholder. Nothing contained herein shall entitle the Holder to any rights as a stockholder of the Company
or to be deemed the holder of any securities that may at any time be issuable on the exercise of the rights hereunder for any purpose
nor shall anything contained herein be construed to confer upon the Holder, as such, any right to vote for the election of directors
or upon any matter submitted to stockholders at any meeting thereof, or to give or withhold consent to any corporate action (whether
upon any recapitalization, issuance of stock, reclassification of stock, change of par value or change of stock to no par value, consolidation,
merger, conveyance or otherwise) or to receive notice of meetings, or to receive dividends or subscription rights or any other rights
of a stockholder of the Company until the rights under the Warrant shall have been exercised and the Shares purchasable upon exercise
of the rights hereunder shall have become deliverable as provided herein.

 

    	20

     

    

 

10.
Market Stand-off. Each Holder agrees that all Shares shall be subject to the market standoff provisions of Section 2.10
of that certain Investors’ Rights Agreement dated the date hereof, by and between the Company and the first purchaser of this Warrant.

 

11.
Miscellaneous.

 

(a)
Amendments. Except as expressly provided herein, neither this Warrant nor any term hereof may be amended, waived, discharged or
terminated other than by a written instrument referencing this Warrant and signed by the Company and a Majority in Interest of the Warrant
Holders; provided, however, that in no event may any such amendment, waiver, discharge or termination materially adversely
affect any holder of a Warrant in a different or disproportionate manner than the other holders of Warrants issued under the Note and
Warrant Purchase Agreement unless agreed to in writing by such materially adversely affected holder. Any amendment, waiver, discharge
or termination effected in accordance with this Section 11(a) shall be binding upon each holder of the Warrants, each future holder
of such Warrants and the Company; provided, however, that no special consideration or inducement may be given to any such holder
in connection with such consent that is not given ratably to all such holders, and that such amendment must apply to all such holders
equally and ratably in accordance with the number of shares of capital stock issuable upon exercise of the Warrants. The Company shall
promptly give notice to all holders of Warrants of any amendment effected in accordance with this Section 11(a).

 

(b)
Waivers. No waiver of any single breach or default shall be deemed a waiver of any other breach or default theretofore or thereafter
occurring.

 

(c)
Notices. All notices and other communications required or permitted hereunder shall be in writing and shall be mailed by registered
or certified mail, postage prepaid, sent by facsimile or electronic mail (if to the Holder) or otherwise delivered by hand, messenger
or courier service addressed:

 

(i)
if to the Holder, to the Holder at the Holder’s address, facsimile number or electronic mail address as shown in the Company’s
records, as may be updated in accordance with the provisions hereof, or until any such Holder so furnishes an address, facsimile number
or electronic mail address to the Company, then to and at the address, facsimile number or electronic mail address of the last holder
of this Warrant for which the Company has contact information in its records; or

 

(ii)
if to the Company, to the attention of the Chief Executive Officer or the Chief Financial Officer of the Company at the Company’s
address as shown on the signature page hereto, or at such other address as the Company shall have furnished to the Holder, with a copy
(which shall not constitute notice) to Thomas E. Puzzo, Law Offices of Thomas E. Puzzo, PLLC, 3823 44th Ave. NE, Seattle, Washington
98105.

 

Each
such notice or other communication shall for all purposes of this Warrant be treated as effective or having been given: (A) if delivered
by hand, messenger or courier service, when delivered; (B) if sent by mail, at the earlier of its receipt or 72 hours after the same
has been deposited in a regularly maintained receptacle for the deposit of the United States mail, addressed and mailed as aforesaid;
or (C) if sent by facsimile, upon confirmation of facsimile transfer or, if sent by electronic mail, upon confirmation of delivery when
directed to the relevant electronic mail address. In the event of any conflict between the Company’s books and records and this
Warrant or any notice delivered hereunder, the Company’s books and records will control absent fraud or error.

 

    	21

     

    

 

(d)
Governing Law. This Warrant and all actions arising out of or in connection with this Warrant shall be governed by and construed
in accordance with the laws of the State of Delaware, without regard to the conflicts of law provisions of the State of Delaware or of
any other state.

 

(e)
Titles and Subtitles. The titles and subtitles used in this Warrant are used for convenience only and are not to be considered
in construing or interpreting this Warrant. All references in this Warrant to sections, paragraphs and exhibits shall, unless otherwise
provided, refer to sections and paragraphs hereof and exhibits attached hereto.

 

(f)
Severability. If any provision of this Warrant becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable
or void, portions of such provision, or such provision in its entirety, to the extent necessary, shall be severed from this Warrant,
and such illegal, unenforceable or void provision shall be replaced with a valid and enforceable provision that will achieve, to the
extent possible, the same economic, business and other purposes of the illegal, unenforceable or void provision. The balance of this
Warrant shall be enforceable in accordance with its terms.

 

(g)
Waiver of Jury Trial. EACH OF THE HOLDER AND THE COMPANY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY AND ALL RIGHT TO
TRIAL BY JURY IN ANY LEGAL PROCEEDING (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATED TO THIS WARRANT. This
Section 11(g) shall not restrict the Holder or the Company from exercising remedies under the Uniform Commercial Code or from
exercising pre-judgment remedies under applicable law.

 

(h)
California Corporate Securities Law. THE SALE OF THE SECURITIES THAT ARE THE SUBJECT OF THIS WARRANT HAS NOT BEEN QUALIFIED WITH
THE COMMISSIONER OF CORPORATIONS OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF SUCH SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART
OF THE CONSIDERATION THEREFOR PRIOR TO SUCH QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM QUALIFICATION BY
SECTION 25100, 25102, OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS WARRANT ARE EXPRESSLY CONDITIONED
UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.

 

(i)
Rights and Obligations Survive Exercise of the Warrant. Except as otherwise provided herein, the rights and obligations of the
Company and the Holder under this Warrant shall survive exercise of this Warrant.

 

(j)
Entire Agreement. Except as expressly set forth herein, this Warrant (including the exhibits attached hereto), the Notes, the
Note and Warrant Purchase Agreement and the other Transaction Documents constitute the entire agreement and understanding of the Company
and the Holder with respect to the subject matters hereof and thereof and supersede all prior agreements and understandings relating
to the subject matters hereof and thereof.

 

(Signature
Page Follows)

 

    	22

     

    

 

The
Company signed this Warrant as of the date first written above.

 

	 	COMPANY:
	 	 
	 	OPTI-HARVEST,
    INC.

 

	 	By:	
	 	Name:	Jonathan
    Destler
	 	Title:	Chief
    Executive Officer

 

	 	Address:
	 	1801
    Century Park East, Suite 520
	 	Los
    Angeles, California 90067

 

(Signature
Page to Opti-Harvest, Inc. Warrant)

 

    	23

     

    

 

EXHIBIT
A

 

NOTICE
OF EXERCISE

 

	TO:	 	OPTI-HARVEST,
    INC. (the “Company”) 
	 	 	 
	Attention:	 	Chief
    Executive Officer

 

	(1)	Exercise.
    The undersigned elects to purchase the following pursuant to the terms of the attached Warrant:

 

	 	Number
    of shares:	
	 	 	 
	 	Type
    of security:	

 

	(2)	Method
    of Exercise. The undersigned elects to exercise the attached Warrant pursuant to:

 

	 	☐ 	A
    cash payment, and tenders herewith payment of the purchase price for such shares in full, together with all applicable transfer taxes,
    if any.
	 	 	 
	 	☐	The
    net issue exercise provisions of Section 2(b) of the attached Warrant.

 

	(3)	Conditional
    Exercise. Is this a conditional exercise pursuant to Section 2(e):

 

	 	☐	Yes	☐ 	No

 

	 	If
    “Yes,” indicate the applicable condition:
	 	 
	 	]

 

	(4)	Stock
    Certificate. Please issue a certificate or certificates representing the shares in the name of:

 

	 	☐ 	The
    undersigned	 
	 	 	 	 
	 	☐ 	Other—Name:	

 

	 	 	Address:	

 

	(5)	Unexercised
                                            Portion of the Warrant. Please issue a new warrant for the unexercised portion of
                                            the attached Warrant in the name of:

 

	 	☐ 	The
    undersigned	 
	 	 	 	 
	 	☐ 	Other—Name:	 

 

	 	 	Address:	

 

	 	☐	Not
    applicable	 

 

	(6)	Investment
    Intent. The undersigned represents and warrants that the aforesaid shares are being acquired for investment for its own account,
    not as a nominee or agent, and not with a view to, or for resale in connection with, the distribution thereof, and that the undersigned
    has no present intention of selling, granting any participation in, or otherwise distributing the shares, nor does it have any contract,
    undertaking, agreement or arrangement for the same.

 

	(7)	Investment
    Representation Statement and Market Stand-Off Agreement. The undersigned has executed, and delivers herewith, an Investment
    Representation Statement and Market Stand-Off Agreement in a form substantially similar to the form attached to the Warrant as Exhibit
    A-1.

 

	(8)	Consent
    to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § 232(e),
    the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation
    Law or the Company’s Certificate of Incorporation or Bylaws by: (i) facsimile telecommunication to the facsimile number provided
    below (or to any other facsimile number for the undersigned in the Company’s records); (ii) electronic mail to the electronic
    mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); (iii) posting
    on an electronic network together with separate notice to the undersigned of such specific posting; or (iv) any other form of electronic
    transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the
    undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation
    Law § 232.

 

	 	
	 	(Print
    name of the warrant holder)
	 	 
	 	
	 	(Signature)
	 	 
	 	
	 	(Name
    and title of signatory, if applicable)
	 	 
	 	
	 	(Date)
	 	 
	 	
	 	(Fax
    number)
	 	 
	 	
	 	(Email
    address)

 

(Signature
Page to the Notice of Exercise)

 

    	24

     

    

 

EXHIBIT
A-l

 

INVESTMENT
REPRESENTATION STATEMENT

AND

MARKET
STAND-OFF AGREEMENT

 

	INVESTOR:	 	
	 	 	 
	COMPANY:	 	OPTI-HARVEST,
    INC.
	 	 	 
	SECURITIES:	 	THE
    WARRANT ISSUED ON ______________, 2021 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF
    (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES)

 

	DATE:		 

 

In
connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and
agrees with, the Company as follows:

 

1.
No Registration. The Investor understands that the Securities have not been, and will not be, registered under the Securities
Act of 1933, as amended (the “Securities Act”), by reason of a specific exemption from the registration provisions
of the Securities Act, the availability of which depends upon, among other things, the bona fide nature of the investment intent
and the accuracy of the Investor’s representations as expressed herein or otherwise made pursuant hereto.

 

2.
Investment Intent. The Investor is acquiring the Securities for investment for its own account, not as a nominee or agent,
and not with a view to, or for resale in connection with, any distribution thereof. The Investor has no present intention of selling,
granting any participation in, or otherwise distributing the Securities, nor does it have any contract, undertaking, agreement or arrangement
for the same.

 

3.
Investment Experience. The Investor has substantial experience in evaluating and investing in private placement transactions
of securities in companies similar to the Company, and has such knowledge and experience in financial or business matters so that it
is capable of evaluating the merits and risks of its investment in the Company and protecting its own interests.

 

4.
Speculative Nature of Investment. The Investor understands and acknowledges that the Company has a limited financial and
operating history and that its investment in the Company is highly speculative and involves substantial risks. The Investor can bear
the economic risk of its investment and is able, without impairing its financial condition, to hold the Securities for an indefinite
period of time and to suffer a complete loss of its investment.

 

    	25

     

    

 

5.
Access to Data. The Investor has had an opportunity to ask questions of officers of the Company, which questions were answered
to its satisfaction. The Investor believes that it has received all the information that it considers necessary or appropriate for deciding
whether to acquire the Securities. The Investor understands that any such discussions, as well as any information issued by the Company,
were intended to describe certain aspects of the Company’s business and prospects, but were not necessarily a thorough or exhaustive
description. The Investor acknowledges that any business plans prepared by the Company have been, and continue to be, subject to change
and that any projections included in such business plans or otherwise are necessarily speculative in nature, and it can be expected that
some or all of the assumptions underlying the projections will not materialize or will vary significantly from actual results.

 

6.
Accredited Investor. The Investor is an “accredited investor” within the meaning of Regulation D, Rule 501(a),
promulgated by the Securities and Exchange Commission and agrees to submit to the Company such further assurances of such status as may
be reasonably requested by the Company.

 

7.
Residency. The residency of the Investor (or, in the case of a partnership or corporation, such entity’s principal
place of business) is correctly set forth on the signature page hereto.

 

8.
Restrictions on Resales. The Investor acknowledges that the Securities must be held indefinitely unless subsequently registered
under the Securities Act or an exemption from such registration is available. The Investor is aware of the provisions of Rule 144 promulgated
under the Securities Act, which permit resale of shares purchased in a private placement subject to the satisfaction of certain conditions,
which may include, among other things, the availability of certain current public information about the Company; the resale occurring
not less than a specified period after a party has purchased and paid for the security to be sold; the number of shares being sold during
any three-month period not exceeding specified limitations; the sale being effected through a “broker’s transaction,”
a transaction directly with a “market maker” or a “riskless principal transaction” (as those terms are defined
in the Securities Act or the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder); and
the filing of a Form 144 notice, if applicable. The Investor acknowledges and understands that the Company may not be satisfying the
current public information requirement of Rule 144 at the time the Investor wishes to sell the Securities and that, in such event, the
Investor may be precluded from selling the Securities under Rule 144 even if the other applicable requirements of Rule 144 have been
satisfied. The Investor understands and acknowledges that, in the event the applicable requirements of Rule 144 are not met, registration
under the Securities Act or an exemption from registration will be required for any disposition of the Securities. The Investor understands
that, although Rule 144 is not exclusive, the Securities and Exchange Commission has expressed its opinion that persons proposing to
sell restricted securities received in a private offering other than in a registered offering or pursuant to Rule 144 will have a substantial
burden of proof in establishing that an exemption from registration is available for those offers or sales and that those persons and
the brokers who participate in the transactions do so at their own risk.

 

9.
No Public Market. The Holder understands and acknowledges that no public market now exists for any of the securities issued
by the Company and that the Company has made no assurances that a public market will ever exist for the Company’s securities.

 

    	26

     

    

 

10.
Brokers and Finders. The Investor has not engaged any brokers, finders or agents in connection with the Securities, and
the Company has not incurred nor will incur, directly or indirectly, as a result of any action taken by the Investor, any liability for
brokerage or finders’ fees or agents’ commissions or any similar charges in connection with the Securities.

 

11.
Legal Counsel. The Investor has had the opportunity to review the Warrant, the exhibits and schedules attached thereto
and the transactions contemplated by the Warrant with its own legal counsel. The Investor is not relying on any statements or representations
of the Company or its agents for legal advice with respect to this investment or the transactions contemplated by the Warrant.

 

12.
Tax Advisors. The Investor has reviewed with its own tax advisors the U.S. federal, state and local and non-U.S. tax consequences
of this investment and the transactions contemplated by the Warrant. With respect to such matters, the Investor relies solely on such
advisors and not on any statements or representations of the Company or any of its agents, written or oral. The Investor understands
that it (and not the Company) shall be responsible for its own tax liability that may arise as a result of this investment or the transactions
contemplated by the Warrant.

 

13.
Market Stand-off. The Investor agrees that all Securities shall be subject to the market standoff provisions of Section
2.10 of the Investors’ Rights Agreement

 

The
Investor is signing this Investment Representation Statement and Market Stand-Off Agreement on the date first written above.

 

	 	INVESTOR
	 	 
	 	
	 	(Print
    name of the investor)
	 	 
	 	
	 	(Signature)
	 	 
	 	
	 	(Name
    and title of signatory, if applicable)
	 	 
	 	
	 	(Street
    address)
	 	 
	 	
	 	(City,
    state and ZIP)

 

    	27

     

    

 

EXHIBIT
B

 

ASSIGNMENT
FORM

 

	ASSIGNOR:	 	
	 	 	 
	COMPANY:	 	OPTI-HARVEST,
    INC.
	 	 	 
	WARRANT:	 	THE
    WARRANT TO PURCHASE SHARES ISSUED ON _____________ ___, 2021 (THE “WARRANT”)

 

	DATE:		 

 

	(1)	Assignment.
    The undersigned registered holder of the Warrant (“Assignor”) assigns and transfers to the assignee named
    below (“Assignee”) all of the rights of Assignor under the Warrant, with respect to the number of shares set forth
    below:

 

	 	Name
    of Assignee:	 

 

	 	Address
    of Assignee:	
	 	 	 
	 	 	 

 

	 	 	 
	 	Number
    of Shares Assigned:	

 

and
does irrevocably constitute and appoint as attorney to make such transfer on the books of OPTI-HARVEST, INC., maintained for the purpose,
with full power of substitution in the premises.

 

	(2)	Obligations
  of Assignee. Assignee agrees to take and hold the Warrant and any shares of stock to be issued upon exercise of the rights
  thereunder (and any shares issuable upon conversion thereof) (the “Securities”) subject to, and to be bound by,
  the terms and conditions set forth in the Warrant to the same extent as if Assignee were the original holder thereof.

 

	(3)	Investment
  Intent. Assignee represents and warrants that the Securities are being acquired for investment for its own account, not as
  a nominee or agent, and not with a view to, or for resale in connection with, the distribution thereof, and that Assignee has no present
  intention of selling, granting any participation in, or otherwise distributing the shares, nor does it have any contract, undertaking,
  agreement or arrangement for the same.

 

	(4)	Investment
  Representation Statement and Market Stand-Off Agreement. Assignee has executed, and delivers herewith, an Investment Representation
  Statement and Market Stand-Off Agreement in a form substantially similar to the form attached to the Warrant as Exhibit A-1.

 

Assignor
and Assignee are signing this Assignment Form on the date first set forth above.

 

	ASSIGNOR	 	ASSIGNEE
	 	 	 
		 	 
	(Print
    name of Assignor)	 	(Print
    name of Assignee)
	 	 	 
	
	 	 
	(Signature
    of Assignor)	 	(Signature
    of Assignee)
		 	
	(Print
    name of signatory, if applicable)	 	(Print
    name of signatory, if applicable)
	 	 	 
	(Print
    title of signatory, if applicable)	 	(Print
    title of signatory, if applicable)
	 	 	 
	Address:	 	Address:
		 	 
		 	 
	 	 	 

 

    	28

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}]]